State Medical Insurance Bureau: The collection of the eleventh batch of drugs follows the principles of stable clinical practice, quality assurance, anti-bids, and anti-involution
2025-09-20 07:45:20
September 20th news, today, the National Medical Insurance Bureau released the eleventh batch of state-organized drug centralized procurement documents. During the formulation and modification of this centralized procurement plan, the principles of "stabilizing clinical practice, ensuring quality, preventing bid containment, and anti-involution" were fully followed. In addition, this centralized procurement will further strengthen the implementation of the selected results. The selected enterprises are required to act as the first responsible person for supply guarantee, respond to medical institutions' orders in a timely manner and complete distribution; medical institutions are required to give priority to purchasing the selected products, complete the agreed purchase quantity on time according to the agreement, and fulfill the obligation of timely settlement of payment.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
